Incidence of Ssi After c.s

Incidence of Surgical Site Infection After Cesarean Section and Compliance With Surgical Site Infection Prevention Stratigies .

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07476261

Enrollment

105

Registered

2026-03-17

Start date

2026-05-01

Completion date

2027-08-01

Last updated

2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Site Infection

Brief summary

aim of the work is to evaluate adherence to preoperative , intraoperative, and postoperative infection preventive measures during cesarean section and to assess it s impact on the incidence of surgical site infection and maternal well-being during 30 days postoperative peroid.

Detailed description

Cesarean Section is one of the most commonly performed obstetric surgical procedures worldwide. Despite its importance in reducing maternal and fetal complications, it is associated with several postoperative complications, the most important of which is Surgical Site Infection. Surgical site infection after cesarean section can lead to increased maternal morbidity, prolonged hospital stay, and higher healthcare costs. Therefore, evaluating the incidence of surgical site infection and assessing adherence to preventive measures are essential for improving the quality of obstetric care. This study aims to determine the incidence of surgical site infection after cesarean section and to assess compliance with infection prevention strategies.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Inclusion criteria

* All women who underwent cesarean section during the study period

Exclusion criteria

* Patients who are lost to follow-up before completion of the 30-day postoperative assessment. Patients with immunocompromised conditions, such as: Chronic corticosteroid therapy. Immunosuppressive treatment. Known HIV infection with severe immunosuppression .

Design outcomes

Primary

Measure	Time frame	Description
incidence of surgical site infection after cesarean section	Baseline	superficial or deep surgical site infection

Countries

Egypt

Contacts

CONTACTmona madgy

mona.helmy1997@gmail.com01145421696

Outcome results